Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (231-240 of 367) with videos related to

Pageof 37
Sort By:
Thrombosis and Haemostasis|September 28, 2012
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind studyJerry Powell, Uri Martinowitz, Jerzy Windyga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2021
Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic CancerFlorian Moik, Gerald Prager, Johannes Thaler, et al.
British Journal of Haematology|April 11, 2019
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancerElla Grilz, Lisa-Marie Mauracher, Florian Posch, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis StudyHanna L Obermeier, Julia Riedl, Cihan Ay, et al.
Scientific Reports|July 31, 2024
Prevalence and incidence of venous thromboembolism in geriatric patients admitted to long-term care hospitalsGernot Wagner, Daniel Steiner, Gerald Ohrenberger, et al.
Blood|October 22, 2024
Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexesJohannes Thaler, Carla Tripisciano, Daniel Kraemmer, et al.
The Lancet. Oncology|October 14, 2016
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Henri Bounameaux, Benjamin Brenner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Rainer Vormittag, Daniela Dunkler, et al.
Clinical Chemistry|May 19, 2007
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variantCihan Ay, Lea V Jungbauer, Thomas Sailer, et al.
European Journal of Haematology|August 10, 2013
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trialsFrancesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, et al.
Pageof 37

Showing results (231-240 of 367) with videos related to

Sort By:
Pageof 37
Thrombosis and Haemostasis|September 28, 2012
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind studyJerry Powell, Uri Martinowitz, Jerzy Windyga, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 2, 2021
Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic CancerFlorian Moik, Gerald Prager, Johannes Thaler, et al.
British Journal of Haematology|April 11, 2019
Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancerElla Grilz, Lisa-Marie Mauracher, Florian Posch, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis StudyHanna L Obermeier, Julia Riedl, Cihan Ay, et al.
Scientific Reports|July 31, 2024
Prevalence and incidence of venous thromboembolism in geriatric patients admitted to long-term care hospitalsGernot Wagner, Daniel Steiner, Gerald Ohrenberger, et al.
Blood|October 22, 2024
Saliva of persons with hemophilia A triggers coagulation via extrinsic tenase complexesJohannes Thaler, Carla Tripisciano, Daniel Kraemmer, et al.
The Lancet. Oncology|October 14, 2016
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Henri Bounameaux, Benjamin Brenner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis StudyCihan Ay, Rainer Vormittag, Daniela Dunkler, et al.
Clinical Chemistry|May 19, 2007
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variantCihan Ay, Lea V Jungbauer, Thomas Sailer, et al.
European Journal of Haematology|August 10, 2013
Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trialsFrancesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, et al.
Pageof 37